Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

NCT07112144

The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.

Prevent Whooping CoughPrevent DiphtheriaPrevent Tetanus

Changchun BCHT Biotechnology Co.1,650 participantsStarted Jun 2025

Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan, China

Data from ClinicalTrials.govTerms

Filters

Filters

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial